American College of Clinical Pharmacy
      Search      Cart
         

IDSAP 2024 Book 1 Infections in Immunocompromised Patients


Member Price:
$80.00
Nonmember Price:
$120.00
ASHP members, please call (913)492-3311 to receive member pricing. Your ASHP membership number and expiration date are required.

Infectious Diseases Pharmacists are essential in preventing and treating a wide range of infections across diverse patient populations. The latest release from the Infectious Diseases Self-Assessment Program (IDSAP) provides invaluable resources and practical strategies for effectively preventing and managing infections in individuals with immune deficiencies.

Daniel B. Chastain, Pharm.D., BCIDP, AAHIVP
Chastain

The target audience for Infections in Immunocompromised Patients is board-certified infectious diseases pharmacists who provide care for individuals with or at risk for infectious diseases. Infections in Immunocompromised Patients contains five learning modules with a total available 21.0 continuing pharmacy education (CPE) credits. Book content was developed under the leadership of Faculty Panel Chair Daniel B. Chastain, Pharm.D., BCIDP, AAHIVP.

 

The first module offers updates on HIV pharmacotherapy, highlighting the significance of integrase strand transfer inhibitor (INSTI)-based regimens. It also explores the unique challenges of managing HIV in select populations, providing practical considerations for clinicians. The second module explores the intricate interplay between innate and acquired immunodeficiencies and their impact on susceptibility to infections. It explores the risk of infections in patients receiving biologic response modifiers for autoimmune inflammatory diseases, offering insights into preventive strategies and management considerations. The third module focuses on vaccination considerations for patients at high risk of infection and the complexities of antimicrobial management in cystic fibrosis. Finally, the fourth and fifth modules consist of case series covering diverse topics, including the prevention of HIV, secondary bacterial and fungal infections associated with viral pneumonitis, infections in individuals on glucocorticoids, and infections in pregnant individuals. Overall, this resource offers valuable insights into the diagnosis, treatment, and prevention of infections across diverse patient populations with immune deficiencies.

Each IDSAP release has continuing education activities that cover the most recent published data (past 3-5 years) on a specific therapeutic area or patient-care problem. This content is provided as an electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

  • Traditional review-style chapters
  • Case series (major sections of learning content bookended by a sample case and its explained answer)
  • Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

All IDSAP chapters and features a

Release Date: May 15, 2024
BCIDP Deadline: November 15, 2024
ACPE Deadline: May 15, 2027

ISBN: 978-1-952291-98-2
Publication Year: 2024
Format: PDF and ePub
Number of Pages: 200

CPE Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are approved by BPS as a provider for the recertification of BCIDP.

BPS is an autonomous division of the American Pharmacists Association. To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for board certification examinations. BPS, through its specialty councils, is responsible for specialty examination content, administration, scoring, and all other aspects of its certification programs. BPS is totally separate and distinct from ACCP. For information about BPS specialty recertification the BPS recertification process, go to: www.bpsweb.org/

To receive recertification credit, posttests must be submitted prior to the recertification posttest deadline (see above). Only completed tests are eligible for credit; no partial or incomplete tests will be processed. You may complete one or all available posttests for credit.

The passing point to earn recertification credit is based on an expert analysis of the assessment items in each posttest. Any posttest submitted before the recertification test deadline that meets this passing point will earn recertification credits. These credits will be assigned as of the date of test submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

In accordance with BPS guidelines concerning remediation for products launched in 2024 and after, posttests that do not reach the passing point for recertification credit will generate a second-chance test option. This test will automatically appear in the learner’s My Account page and will have assessment items presented in a different order. To qualify for recertification credit, the second-chance test must be submitted before the recertification deadline stated above.

The ACCP Recertification Dashboard is a free online tool that can track recertification credits as they are earned through ACCP and schedule new opportunities for credits from upcoming ACCP professional development programs. Questions regarding the number of hours required for recertification should be directed to BPS at www.bpsweb.org.


Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.